Heron Therapeutics, Inc. (HRTX)
0.3765
+0.01
(+4.01%)
USD |
NASDAQ |
Oct 15, 16:00
0.3752
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Cash from Operations (TTM) : -11.61M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.61M |
| March 31, 2026 | -20.26M |
| December 31, 2025 | -27.59M |
| September 30, 2025 | -30.19M |
| June 30, 2025 | -28.15M |
| March 31, 2025 | -21.88M |
| December 31, 2024 | -22.53M |
| September 30, 2024 | -8.294M |
| June 30, 2024 | -20.84M |
| March 31, 2024 | -43.40M |
| December 31, 2023 | -58.79M |
| September 30, 2023 | -98.78M |
| June 30, 2023 | -126.66M |
| March 31, 2023 | -127.87M |
| December 31, 2022 | -146.91M |
| September 30, 2022 | -154.64M |
| June 30, 2022 | -170.74M |
| March 31, 2022 | -205.36M |
| December 31, 2021 | -203.35M |
| September 30, 2021 | -210.65M |
| June 30, 2021 | -199.54M |
| March 31, 2021 | -193.82M |
| December 31, 2020 | -184.82M |
| September 30, 2020 | -159.24M |
| June 30, 2020 | -142.66M |
| Date | Value |
|---|---|
| March 31, 2020 | -108.49M |
| December 31, 2019 | -124.58M |
| September 30, 2019 | -131.09M |
| June 30, 2019 | -141.50M |
| March 31, 2019 | -179.12M |
| December 31, 2018 | -191.80M |
| September 30, 2018 | -205.47M |
| June 30, 2018 | -210.13M |
| March 31, 2018 | -181.43M |
| December 31, 2017 | -170.30M |
| September 30, 2017 | -161.67M |
| June 30, 2017 | -157.25M |
| March 31, 2017 | -152.33M |
| December 31, 2016 | -134.10M |
| September 30, 2016 | -118.73M |
| June 30, 2016 | -102.50M |
| March 31, 2016 | -91.21M |
| December 31, 2015 | -78.53M |
| September 30, 2015 | -68.23M |
| June 30, 2015 | -67.58M |
| March 31, 2015 | -64.24M |
| December 31, 2014 | -60.28M |
| September 30, 2014 | -57.05M |
| June 30, 2014 | -50.17M |
| March 31, 2014 | -48.52M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -155.18M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |